Encephalitis caused by Japanese encephalitis virus occurs in annual epidemics throughout Asia, making it the principal cause of epidemic viral encephalitis in the world. No currently available vaccine has demonstrated efficacy in preventing this disease in a controlled trial. We performed a placebo-controlled, blinded, randomized trial in a northern Thai province, with two doses of monovalent (Nakayama strain) or bivalent (Nakayama plus Beijing strains) inactivated, purified Japanese encephalitis vaccine made from whole virus derived from mouse brain. We examined the effect of these vaccines on the incidence and severity of Japanese encephalitis and dengue hemorrhagic fever, a disease caused by a closely related flavivirus. Between November 1984 and March 1985, 65,224 children received two doses of monovalent Japanese encephalitis vaccine (n = 21,628), bivalent Japanese encephalitis vaccine (n = 22,080), or tetanus toxoid placebo (n = 21,516), with only minor side effects. The cumulative attack rate for encephalitis due to Japanese encephalitis virus was 51 per 100,000 in the placebo group and 5 per 100,000 in each vaccine group. The efficacy in both vaccine groups combined was 91 percent (95 percent confidence interval, 70 to 97 percent). Attack rates for dengue hemorrhagic fever declined, but not significantly. The severity of cases of dengue was also reduced. We conclude that two doses of inactivated Japanese encephalitis vaccine, either monovalent or bivalent, protect against encephalitis due to Japanese encephalitis virus and may have a limited beneficial effect on the severity of dengue hemorrhagic fever.
Source Information
U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
This article has been cited by other articles:
Tang, F., Zhang, J.-S., Liu, W., Zhao, Q.-M., Zhang, F., Wu, X.-M., Yang, H., Ly, H., Cao, W.-C.
(2008). Failure of Japanese Encephalitis Vaccine and Infection in Inducing Neutralizing Antibodies against West Nile Virus, People's Republic of China. Am J Trop Med Hyg
78: 999-1001
[Abstract][Full Text]
Gibbons, R. V., Kalanarooj, S., Jarman, R. G., Nisalak, A., Vaughn, D. W., Endy, T. P., Mammen, M. P. Jr, Srikiatkhachorn, A.
(2007). Analysis of Repeat Hospital Admissions for Dengue to Estimate the Frequency of Third or Fourth Dengue Infections Resulting in Admissions and Dengue Hemorrhagic Fever, and Serotype Sequences. Am J Trop Med Hyg
77: 910-913
[Abstract][Full Text]
ITODA, I., MASUDA, G., SUGANUMA, A., IMAMURA, A., AJISAWA, A., YAMADA, K.-I., YABE, S., TAKASAKI, T., KURANE, I., TOTSUKA, K., NEGISHI, M.
(2006). CLINICAL FEATURES OF 62 IMPORTED CASES OF DENGUE FEVER IN JAPAN.. Am J Trop Med Hyg
75: 470-474
[Abstract][Full Text]
Grabenstein, J. D., Pittman, P. R., Greenwood, J. T., Engler, R. J.M.
(2006). Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects. Epidemiol Rev
28: 3-26
[Abstract][Full Text]
Kumar, P., Krishna, V. D., Sulochana, P., Nirmala, G., Haridattatreya, M., Satchidanandam, V.
(2004). Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J. Gen. Virol.
85: 471-482
[Abstract][Full Text]
Zhao, Z., Wakita, T., Yasui, K.
(2003). Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice. J. Virol.
77: 4248-4260
[Abstract][Full Text]
Endy, T. P., Nisalak, A., Chunsuttiwat, S., Libraty, D. H., Green, S., Rothman, A. L., Vaughn, D. W., Ennis, F. A.
(2002). Spatial and Temporal Circulation of Dengue Virus Serotypes: A Prospective Study of Primary School Children in Kamphaeng Phet, Thailand. Am J Epidemiol
156: 52-59
[Abstract][Full Text]
Solomon, T., Dung, N. M., Kneen, R., Thao, L. T. T., Gainsborough, M., Nisalak, A., Day, N. P. J., Kirkham, F. J., Vaughn, D. W., Smith, S., White, N. J.
(2002). Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain
125: 1084-1093
[Abstract][Full Text]
Tiroumourougane, S V, Raghava, P, Srinivasan, S
(2002). Japanese viral encephalitis. Postgrad. Med. J.
78: 205-215
[Abstract][Full Text]
Dennehy, P. H.
(2001). Active Immunization in the United States: Developments over the Past Decade. Clin. Microbiol. Rev.
14: 872-908
[Abstract][Full Text]
Solomon, T., Cardosa, M. J.
(2000). Emerging arboviral encephalitis. BMJ
321: 1484-1485
[Full Text]
Vaughn, D. W.
(2000). Invited Commentary: Dengue Lessons from Cuba. Am J Epidemiol
152: 800-803
[Abstract][Full Text]
Solomon, T., Dung, N. M., Kneen, R., Gainsborough, M., Vaughn, D. W, Khanh, V. T.
(2000). NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Japanese encephalitis. J. Neurol. Neurosurg. Psychiatry
68: 405-415
[Full Text]
Monath, T. P., Levenbook, I., Soike, K., Zhang, Z.-X., Ratterree, M., Draper, K., Barrett, A. D. T., Nichols, R., Weltzin, R., Arroyo, J., Guirakhoo, F.
(2000). Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys. J. Virol.
74: 1742-1751
[Abstract][Full Text]
Chen, H.-W., Pan, C.-H., Liau, M.-Y., Jou, R., Tsai, C.-J., Wu, H.-J., Lin, Y.-L., Tao, M.-H.
(1999). Screening of Protective Antigens of Japanese Encephalitis Virus by DNA Immunization: a Comparative Study with Conventional Viral Vaccines. J. Virol.
73: 10137-10145
[Abstract][Full Text]
Konishi, E., Yamaoka, M., Khin-Sane-Win, , Kurane, I., Takada, K., Mason, P. W.
(1999). The Anamnestic Neutralizing Antibody Response Is Critical for Protection of Mice from Challenge following Vaccination with a Plasmid Encoding the Japanese Encephalitis Virus Premembrane and Envelope Genes. J. Virol.
73: 5527-5534
[Abstract][Full Text]
Spaulding, A. C., Kurane, I., Ennis, F. A., Rothman, A. L.
(1999). Analysis of Murine CD8+ T-Cell Clones Specific for the Dengue Virus NS3 Protein: Flavivirus Cross-Reactivity and Influence of Infecting Serotype. J. Virol.
73: 398-403
[Abstract][Full Text]
Aihara, H., Takasaki, T., Matsutani, T., Suzuki, R., Kurane, I.
(1998). Establishment and Characterization of Japanese Encephalitis Virus-Specific, Human CD4+ T-Cell Clones: Flavivirus Cross-Reactivity, Protein Recognition, and Cytotoxic Activity. J. Virol.
72: 8032-8036
[Abstract][Full Text]
Lin, Y.-L., Chen, L.-K., Liao, C.-L., Yeh, C.-T., Ma, S.-H., Chen, J.-L., Huang, Y.-L., Chen, S.-S., Chiang, H.-Y.
(1998). DNA Immunization with Japanese Encephalitis Virus Nonstructural Protein NS1 Elicits Protective Immunity in Mice. J. Virol.
72: 191-200
[Abstract][Full Text]
(1988). EFFECTIVE VACCINE FOR JAPANESE ENCEPHALITIS. JWatch General
1988: 5-5
[Full Text]
Previous
